Access Bio (XKRX:950130) Other Long Term Assets : ₩132,588 Mil (As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Access Bio Other Long Term Assets?

Access Bio's other long-term assets for the quarter that ended in Mar. 2024 was ₩132,588 Mil.

Access Bio's quarterly other long-term assets increased from Sep. 2023 (₩81,318 Mil) to Dec. 2023 (₩131,995 Mil) and increased from Dec. 2023 (₩131,995 Mil) to Mar. 2024 (₩132,588 Mil).

Access Bio's annual other long-term assets increased from Dec. 2021 (₩31,515 Mil) to Dec. 2022 (₩37,717 Mil) and increased from Dec. 2022 (₩37,717 Mil) to Dec. 2023 (₩131,995 Mil).

Access Bio Other Long Term Assets Historical Data

The historical data trend for Access Bio's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Access Bio Other Long Term Assets Chart

Access Bio Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

Get a 7-Day Free Trial

7,854.81

7,173.67

31,514.58

37,717.39

131,994.64

Access Bio Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long Term Assets	Get a 7-Day Free Trial															31,476.13	37,727.37	81,317.60	131,994.64	132,588.04

Access Bio Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Access Bio (XKRX:950130) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Access Bio Inc (XKRX:950130) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

65 Clyde Road, Suite A, Somerset, NJ, USA, 08873

Website

http://www.accessbio.net

Access Bio Inc is a United States based bio company engaged in the research, development, and manufacturing of in vitro rapid diagnostic tests, biosensor, and molecular diagnostic products. The products are for the prevention and early diagnosis of infectious diseases. The company's core in vitro-diagnostic technology includes immunochemical, biochemical and molecular products. The company offers products for Rapid Diagnostic Tests including CareStart G6PD RDT, CareStart Malaria, CareStart Dengue Combo, and CareStart Scrub Typhus IgM; Biosensors product includes CareStart G6PD Biosensor, and Molecular Diagnostics products include CareStart HPV and CareStart CAH.

Access Bio (XKRX:950130) Headlines

No Headlines